Cargando…

Estimating Trends in the Proportion of Transmitted and Acquired HIV Drug Resistance in a Long Term Observational Cohort in Germany

OBJECTIVE: We assessed trends in the proportion of transmitted (TDR) and acquired (ADR) HIV drug resistance and associated mutations between 2001 and 2011 in the German ClinSurv-HIV Drug Resistance Study. METHOD: The German ClinSurv-HIV Drug Resistance Study is a subset of the German ClinSurv-HIV Co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Daniel, Kollan, Christian, Fätkenheuer, Gerd, Schülter, Eugen, Stellbrink, Hans-Jürgen, Noah, Christian, Jensen, Björn-Erik Ole, Stoll, Matthias, Bogner, Johannes R., Eberle, Josef, Meixenberger, Karolin, Kücherer, Claudia, Hamouda, Osamah, Bartmeyer, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141736/ https://www.ncbi.nlm.nih.gov/pubmed/25148412 http://dx.doi.org/10.1371/journal.pone.0104474

Ejemplares similares

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany
por: Schmidt, Daniel, et al.
Publicado: (2015)

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
por: Meixenberger, Karolin, et al.
Publicado: (2017)

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
por: Stoll, Matthias, et al.
Publicado: (2011)

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses
por: Hauser, Andrea, et al.
Publicado: (2018)

The denominator problem: Estimating MSM-specific incidence of sexually transmitted infections and prevalence of HIV using population sizes of MSM derived from Internet surveys
por: Marcus, Ulrich, et al.
Publicado: (2009)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022)

Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort
por: Hauser, Andrea, et al.
Publicado: (2014)

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005
por: Gilsdorf, Andreas, et al.
Publicado: (2010)

Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2020)

Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017
por: Stecher, Melanie, et al.
Publicado: (2021)

STI tests and proportion of positive tests in female sex workers attending local public health departments in Germany in 2010/11
por: Bremer, Viviane, et al.
Publicado: (2016)

Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy
por: Karo, Basel, et al.
Publicado: (2017)

Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease
por: Kastenbauer, U, et al.
Publicado: (2009)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

1269. Cohort Profile: The Translational Platform HIV (TP-HIV), a Multicenter Cohort Project in Germany
por: Stecher, Melanie, et al.
Publicado: (2019)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

Analysis of contemporary HIV/AIDS health care costs in Germany: Driving factors and distribution across antiretroviral therapy lines
por: Treskova, Marina, et al.
Publicado: (2016)

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020
por: Fiebig, Uwe, et al.
Publicado: (2023)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Conversation about Serostatus decreases risk of acquiring HIV: results from a case control study comparing MSM with recent HIV infection and HIV negative controls
por: Santos-Hövener, Claudia, et al.
Publicado: (2014)

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion
por: Rüsenberg, Robin, et al.
Publicado: (2021)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Public health microbiology in Germany: 20 years of national reference centers and consultant laboratories
por: Beermann, Sandra, et al.
Publicado: (2015)

A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling
por: Zimmermann, Ruth, et al.
Publicado: (2014)

Viral hepatitis in Germany: poor vaccination coverage and little knowledge about transmission in target groups
por: Schenkel, Karl, et al.
Publicado: (2008)

Treatment strategies for treatment naïve HIV patients in Germany: evidence from claims data
por: Mahlich, Jörg, et al.
Publicado: (2015)

High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany
por: Müller, Jana, et al.
Publicado: (2017)

HIV-induced immune activation - pathogenesis and clinical relevance. Summary of a workshop organised by the German AIDs Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008
por: Stellbrink, HJ, et al.
Publicado: (2010)

Proportionality, Evidence and the COVID-19-Jurisprudence in Germany
por: Berger, Pascal
Publicado: (2022)

Cost-savings and potential cost-savings through the distribution of generic antiretroviral drugs within the statutory health insurance market of Germany between January 2017 and June 2019
por: Lottes, Matthäus, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m2blpkde1qfo1pdb0ddea1ola7